LivaNova plc (LIVN) Tops Q4 EPS by 8c; Offers FY23 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
February 22, 2023 6:00 AM ESTLONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023.
Fourth-Quarter Financial Summary and Highlights1
Fourth-quarter revenue of $274.9 million increased 1.8 percent on a reported basis and 6.2 percent on a constant-currency basis, as compared to the prior-year period Fourth-quarter U.S. GAAP diluted earnings per share was $0.03 and adjusted diluted earnings per share was $0.81 Completed first clinical cases using EssenzTM, the Company's... More